Activity of Ethics Committees in Europe on issues related to clinical trials in paediatrics: Results of a survey

Pharmaceuticals Policy and Law

Volumn 11, Issue 1-2, 2009, Pages 79-87

  Altavilla, A ^a   Giaquinto, C ^b   Giocanti, D ^a   Manfredi, C ^c   P Aboulker, J ^d   Bartoloni, F ^e   Cattani, E ^c   Lo Giudice, M ^f   Mellado Pena M J ^g   Nagler, R ^h   Peterson, C ⁱ   Vajnerova, O ^j   Bonifazi, F ^e   Ceci, A ^c  

^a AIX MARSEILLE UNIVERSITY   (France)

^b UNIVERSITY OF PADOVA   (Italy)

^c Mediterranean University Division of Legal Medicine ^*  (Italy)

^d Inst Natl de la Sante et de la R   (France)

^e IRIDIA srl   (Italy)

^f AUSL 6   (Italy)

^g HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^h TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

ⁱ LINKÖPING UNIVERSITY   (Sweden)

^j INSTITUTE OF PHYSIOLOGY   (Czech Republic)

more..

Author keywords

Children assent; Clinical trials; Ethics; Informed consent; Paediatrics; TEDDY

Indexed keywords

EID: 85013593756     PISSN: 13892827     EISSN: 2210495X     Source Type: Journal    
DOI: 10.3233/PPL-2009-0208     Document Type: Article

References (21)

1. A. Altavilla, C. Giaquinto and A. Ceci, European survey on ethical and legal framework of clinical trials in paediatrics: results and perspectives, J Int Bióthique 19(4) (2008), in press.
2. Council of Europe, Convention on Human Rights and Biomedicine, Strasbourg (1997). Entry into force in 1999.
3. Council of Europe, Additional Protocol to the Convention on Human Rights and Biomedicine, concerning Biomedical Research, Strasbourg (2005). Entry into force in 2007.
4. European Commission Enterprise Directorate General, Better Medicines for Children. Proposed regulatory actions on paediatric medicinal products, Consultation document, Brussels (2002).
5. European Commission Enterprise Directorate General, Ethical considerations for clinical trials on medicinal products conducted with the paediatric population. Recommendations of the ad hoc group for the development of implementing guidelines for Directive 2001/20/EC relating to good clinical practice in the conduct of clinical trials on medicinal products for human use, available from URL http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/homev10.htm (accessed 17 September 2008).
6. European Commission, Science and Society in Europe, Action Plan, available from URL http://ec.europa.eu/research/science-society/action-plan/action-plan en. html (accessed 17 September 2008).
7. European Parliament and the Council of the European Union, Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use, OJL 121 (2001), 34-44.
8. Federal Republic of Germany, Arzneimittelgesetz - AMG - Medicinal Products Act (the Drug Law), as modified by the Article 12 of the Law of 14th August 2006, which entered into force on 18th August 2006, in: Federal Law Gazette I, p. 1869.
9. D. Gill, F.P. Crawley, M. LoGiudice, S. Grosek, R. Kurz, M. de Lourdes-Levy, S. Mjönes, D. Nicolopoulos, A. Rubino, P.J. Sauer, M. Siimes, M. Weindig, M. Zach and T.L. Chambers; Ethics Working Group of the Confederation of European Specialists in Pediatrics, Guidelines for informed consent in biomedical research involving paediatric populations as research participants, Eur J Pediatr 162(7-8) (2003), 455-458.
10. R. Halila, Assessing the ethics of medical research in emergency settings: how do international regulations work in practice? Sci Eng Ethics 3(3) (2007), 305-313.
11. HMA. Heads of Medicines Agencies website, http://www.hma.eu (accessed 17 September 2008).
12. C. Huriet, Introduction, in: Ethical Eye: Biomedical research, Council of Europe (2004) 17.
13. J.E. John, The child’s right to participate in research: myth or misconception? Br J Nurs 16(3) (2007), 157-160.
14. C.A. Knox and P.V. Burkhart, Issues related to children participating in clinical research, J Pediatr Nurs 22(4) (2007), 310-318.
15. Ministère de la santéet des solidarities, Décret n°2006-477 du 26 avril 2006 modifiant le chapitre Ier du titre II du livre Ier de la première partie du code de la santépublique relatif aux recherches biomédicales (dispositions réglementaires). Art. R 1123-4, OJ 99 du 27 of April 2006
16. C.D. Mitchell, Harmful impact of EU clinical trials directive: … while paediatric oncology is being scuppered, BMJ 332(7542) (2006), 666.
17. M.J. Piccart, A. Goldhirsch, M.l Martin, J. Crown, R. Jakesz, H. Torbol Mouridsen, J. Bergh, J. G.M.Klijn, G. von Minckwitz, H. Rochéand J. Jassem, European academics fight for the health of clinical trials, Rapid Responses, BMJ (2003 July 7).
18. A. Plomer, Participation of children in clinical trials: UK, European and international legal perspectives on consent, Med Law Int 5(1) (2000), 1-24.
19. République Francaise. Loi n.2004-806 relative à la politique de santépublique of 9 August 2004. Art. L.1122-2-I-2. OJ n.185 of 11 August 2004.
20. A. Saint Raymond and D. Brasseur, Development of medicines for children in Europe: ethical implications, Paediatr Respir Rev 6(1) (2005), 45-51.
21. M.A. Weingarten, M. Paul and L. Leibovici, Assessing ethics of trials in systematic reviews, BMJ 328(7446) (2004), 1013-1014.